We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Brown Fat Hormone Signaling Prevents Obesity by Modulating Liver Lipid Metabolism

By LabMedica International staff writers
Posted on 25 Nov 2014
Print article
A hormone produced by brown adipose tissue has been determined to modulate the activity of liver cells that metabolize sugar into fats and is apparently linked to the development of metabolic disorders such as type II diabetes, nonalcoholic fatty liver disease, and obesity.

Investigators at the University of Michigan (Ann Arbor, USA) worked with genetically engineered mice in which the production of the hormone neuregulin 4 (Nrg4) was either blocked or enhanced. The neuregulins, including NRG4, activate type-1 growth factor receptors to initiating cell-to-cell signaling through tyrosine phosphorylation.

In a paper published in the November 17, 2014, online edition of the journal Nature Medicine, the investigators reported that Nrg4 was highly expressed in adipose tissues, enriched in brown fat, and markedly increased during brown adipocyte differentiation. Adipose tissue Nrg4 expression was reduced in rodent and human obesity. Gain- and loss-of-function studies in genetically engineered mice demonstrated that Nrg4 protected against diet-induced insulin resistance and accumulation of fats in the liver by reducing lipogenic signaling.

Mice genetically engineered to lack the gene for NRG4 became obese and developed symptoms of type II diabetes and fatty liver disease. Animals in which NRG4 levels were genetically elevated were protected from these metabolic disorders when fed a high-calorie, high-fat diet.

Senior author Dr. Jiandie Lin, associate professor of cell and developmental biology at the University of Michigan, said, "In all models of obesity, NRG4 expression is reduced. We think obesity is a state of NRG4 deficiency. Realistically, there are still many challenges to figuring out how it acts in the body and might be used as a drug, but in general, we know that NRG4 is beneficial for body metabolism and are excited about its potential."

Related Links:

University of Michigan


Gold Member
Hematology Analyzer
Swelab Lumi
Automated Blood Typing System
IH-500 NEXT
New
Tabletop Centrifuge
Mikro 185
New
Hepatitis B Virus Test
HBs Ab – ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.